3,7-dihydroxy-12-oxocholanoic acid and methotrexate

3,7-dihydroxy-12-oxocholanoic acid has been researched along with methotrexate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, G; Fawcett, JP; Mikov, M; Tucker, IG	1

Other Studies

1 other study(ies) available for 3,7-dihydroxy-12-oxocholanoic acid and methotrexate

Article	Year
Monoketocholate can decrease transcellular permeation of methotrexate across Caco-2 cell monolayers and reduce its intestinal absorption in rat. The Journal of pharmacy and pharmacology, 2009, Volume: 61, Issue:7 Topics: Adjuvants, Pharmaceutic; Administration, Oral; Animals; Area Under Curve; Biological Transport; Caco-2 Cells; Cell Membrane Permeability; Chenodeoxycholic Acid; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Humans; Immunosuppressive Agents; Intestinal Absorption; Male; Methotrexate; Rats; Rats, Wistar; Sodium Cholate	2009

Article

Year

Monoketocholate can decrease transcellular permeation of methotrexate across Caco-2 cell monolayers and reduce its intestinal absorption in rat.

The Journal of pharmacy and pharmacology, 2009, Volume: 61, Issue:7

Topics: Adjuvants, Pharmaceutic; Administration, Oral; Animals; Area Under Curve; Biological Transport; Caco-2 Cells; Cell Membrane Permeability; Chenodeoxycholic Acid; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Humans; Immunosuppressive Agents; Intestinal Absorption; Male; Methotrexate; Rats; Rats, Wistar; Sodium Cholate

2009